Global Peptide API CDMO Services Competitive Landscape Professional Research Report 2025
Market Overview
According to DIResearch's in-depth investigation and research, the global Peptide API CDMO Services market size will reach 2,940.82 Million USD in 2025 and is projected to reach 7,723.19 Million USD by 2032, with a CAGR of 14.79% (2025-2032). Notably, the China Peptide API CDMO Services market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Peptide API CDMO (Contract Development and Manufacturing Organization) services involve the synthesis, development, and production of peptide Active Pharmaceutical Ingredients (APIs) for pharmaceutical companies. These services encompass the entire process of peptide drug development, from initial research and design to commercial-scale manufacturing. CDMOs specializing in peptide APIs offer expertise in peptide chemistry, process optimization, analytical methods development, and regulatory compliance. They assist pharmaceutical companies in custom synthesis of peptides, process scale-up, formulation development, and manufacturing of high-quality peptide APIs for clinical trials and commercialization. Peptide API CDMO services provide pharmaceutical companies with the flexibility, efficiency, and expertise needed to accelerate drug development timelines and bring peptide-based therapeutics to market.
The major global suppliers of Peptide API CDMO Services include Bachem, PolyPeptide, CordenPharma, AmbioPharm, USV Peptides, Thermofischer, Bio Basic, JPT, Genscript, Xinbang Pharma, ScinoPharm, SN Biopharm, CBL, Piramal Pharma, CPC Scientific, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Peptide API CDMO Services. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Peptide API CDMO Services market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Peptide API CDMO Services market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Peptide API CDMO Services industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Peptide API CDMO Services Include:
Bachem
PolyPeptide
CordenPharma
AmbioPharm
USV Peptides
Thermofischer
Bio Basic
JPT
Genscript
Xinbang Pharma
ScinoPharm
SN Biopharm
CBL
Piramal Pharma
CPC Scientific
Peptide API CDMO Services Product Segment Include:
GMP Services
Non-GMP Services
Peptide API CDMO Services Product Application Include:
Commercial
Scientific Research
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Peptide API CDMO Services Industry PESTEL Analysis
Chapter 3: Global Peptide API CDMO Services Industry Porter’s Five Forces Analysis
Chapter 4: Global Peptide API CDMO Services Major Regional Market Size and Forecast Analysis
Chapter 5: Global Peptide API CDMO Services Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Peptide API CDMO Services Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Peptide API CDMO Services Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Peptide API CDMO Services Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Peptide API CDMO Services Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Peptide API CDMO Services Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Peptide API CDMO Services Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Peptide API CDMO Services Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Peptide API CDMO Services market size will reach 2,940.82 Million USD in 2025 and is projected to reach 7,723.19 Million USD by 2032, with a CAGR of 14.79% (2025-2032). Notably, the China Peptide API CDMO Services market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Peptide API CDMO (Contract Development and Manufacturing Organization) services involve the synthesis, development, and production of peptide Active Pharmaceutical Ingredients (APIs) for pharmaceutical companies. These services encompass the entire process of peptide drug development, from initial research and design to commercial-scale manufacturing. CDMOs specializing in peptide APIs offer expertise in peptide chemistry, process optimization, analytical methods development, and regulatory compliance. They assist pharmaceutical companies in custom synthesis of peptides, process scale-up, formulation development, and manufacturing of high-quality peptide APIs for clinical trials and commercialization. Peptide API CDMO services provide pharmaceutical companies with the flexibility, efficiency, and expertise needed to accelerate drug development timelines and bring peptide-based therapeutics to market.
The major global suppliers of Peptide API CDMO Services include Bachem, PolyPeptide, CordenPharma, AmbioPharm, USV Peptides, Thermofischer, Bio Basic, JPT, Genscript, Xinbang Pharma, ScinoPharm, SN Biopharm, CBL, Piramal Pharma, CPC Scientific, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Peptide API CDMO Services. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Peptide API CDMO Services market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Peptide API CDMO Services market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Peptide API CDMO Services industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Peptide API CDMO Services Include:
Bachem
PolyPeptide
CordenPharma
AmbioPharm
USV Peptides
Thermofischer
Bio Basic
JPT
Genscript
Xinbang Pharma
ScinoPharm
SN Biopharm
CBL
Piramal Pharma
CPC Scientific
Peptide API CDMO Services Product Segment Include:
GMP Services
Non-GMP Services
Peptide API CDMO Services Product Application Include:
Commercial
Scientific Research
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Peptide API CDMO Services Industry PESTEL Analysis
Chapter 3: Global Peptide API CDMO Services Industry Porter’s Five Forces Analysis
Chapter 4: Global Peptide API CDMO Services Major Regional Market Size and Forecast Analysis
Chapter 5: Global Peptide API CDMO Services Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Peptide API CDMO Services Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Peptide API CDMO Services Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Peptide API CDMO Services Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Peptide API CDMO Services Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Peptide API CDMO Services Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Peptide API CDMO Services Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Peptide API CDMO Services Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
1 PEPTIDE API CDMO SERVICES MARKET OVERVIEW
1.1 Product Definition and Statistical Scope
1.2 Peptide API CDMO Services Product by Type
1.2.1 GMP Services
1.2.2 Non-GMP Services
1.3 Peptide API CDMO Services Product by Application
1.3.1 Commercial
1.3.2 Scientific Research
1.3.3 Other
1.4 Global Peptide API CDMO Services Market Size Analysis (2020-2032)
1.5 Peptide API CDMO Services Market Development Status and Trends
1.5.1 Peptide API CDMO Services Industry Development Status Analysis
1.5.2 Peptide API CDMO Services Industry Development Trends Analysis
2 PEPTIDE API CDMO SERVICES MARKET PESTEL ANALYSIS
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 PEPTIDE API CDMO SERVICES MARKET PORTER'S FIVE FORCES ANALYSIS
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 GLOBAL PEPTIDE API CDMO SERVICES MARKET ANALYSIS BY REGIONS
4.1 Global Peptide API CDMO Services Overall Market: 2024 VS 2025 VS 2032
4.2 Global Peptide API CDMO Services Revenue and Forecast Analysis (2020-2032)
4.2.1 Global Peptide API CDMO Services Revenue and Market Share by Region (2020-2025)
4.2.2 Global Peptide API CDMO Services Revenue Forecast by Region (2026-2032)
5 GLOBAL PEPTIDE API CDMO SERVICES MARKET SIZE BY TYPE AND APPLICATION
5.1 Global Peptide API CDMO Services Market Size by Type (2020-2032)
5.2 Global Peptide API CDMO Services Market Size by Application (2020-2032)
6 NORTH AMERICA
6.1 North America Peptide API CDMO Services Market Size and Growth Rate Analysis (2020-2032)
6.2 North America Key Suppliers Analysis
6.3 North America Peptide API CDMO Services Market Size by Type
6.4 North America Peptide API CDMO Services Market Size by Application
6.5 North America Peptide API CDMO Services Market Size by Country
6.5.1 US
6.5.2 Canada
7 EUROPE
7.1 Europe Peptide API CDMO Services Market Size and Growth Rate Analysis (2020-2032)
7.2 Europe Key Suppliers Analysis
7.3 Europe Peptide API CDMO Services Market Size by Type
7.4 Europe Peptide API CDMO Services Market Size by Application
7.5 Europe Peptide API CDMO Services Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 CHINA
8.1 China Peptide API CDMO Services Market Size and Growth Rate Analysis (2020-2032)
8.2 China Key Suppliers Analysis
8.3 China Peptide API CDMO Services Market Size by Type
8.4 China Peptide API CDMO Services Market Size by Application
9 APAC (EXCL. CHINA)
9.1 APAC (excl. China) Peptide API CDMO Services Market Size and Growth Rate Analysis (2020-2032)
9.2 APAC (excl. China) Key Suppliers Analysis
9.3 APAC (excl. China) Peptide API CDMO Services Market Size by Type
9.4 APAC (excl. China) Peptide API CDMO Services Market Size by Application
9.5 APAC (excl. China) Peptide API CDMO Services Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Southeast Asia
10 LATIN AMERICA
10.1 Latin America Peptide API CDMO Services Market Size and Growth Rate Analysis (2020-2032)
10.2 Latin America Key Suppliers Analysis
10.3 Latin America Peptide API CDMO Services Market Size by Type
10.4 Latin America Peptide API CDMO Services Market Size by Application
10.5 Latin America Peptide API CDMO Services Market Size by Country
10.5.1 Mexico
10.5.2 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Peptide API CDMO Services Market Size and Growth Rate Analysis (2020-2032)
11.2 Middle East & Africa Key Suppliers Analysis
11.3 Middle East & Africa Peptide API CDMO Services Market Size by Type
11.4 Middle East & Africa Peptide API CDMO Services Market Size by Application
11.5 Middle East & Africa Peptide API CDMO Services Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 COMPETITION BY SUPPLIERS
12.1 Global Peptide API CDMO Services Market Revenue by Key Suppliers (2021-2025)
12.2 Peptide API CDMO Services Competitive Landscape Analysis and Market Dynamic
12.2.1 Peptide API CDMO Services Competitive Landscape Analysis
12.2.2 Global Key Suppliers Headquarter Location and Key Area Sales
12.2.3 Market Dynamic
13 KEY COMPANIES ANALYSIS
13.1 Bachem
13.1.1 Bachem Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 Bachem Peptide API CDMO Services Product Portfolio
13.1.3 Bachem Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.2 PolyPeptide
13.2.1 PolyPeptide Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 PolyPeptide Peptide API CDMO Services Product Portfolio
13.2.3 PolyPeptide Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.3 CordenPharma
13.3.1 CordenPharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 CordenPharma Peptide API CDMO Services Product Portfolio
13.3.3 CordenPharma Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.4 AmbioPharm
13.4.1 AmbioPharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 AmbioPharm Peptide API CDMO Services Product Portfolio
13.4.3 AmbioPharm Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.5 USV Peptides
13.5.1 USV Peptides Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 USV Peptides Peptide API CDMO Services Product Portfolio
13.5.3 USV Peptides Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.6 Thermofischer
13.6.1 Thermofischer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 Thermofischer Peptide API CDMO Services Product Portfolio
13.6.3 Thermofischer Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.7 Bio Basic
13.7.1 Bio Basic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.7.2 Bio Basic Peptide API CDMO Services Product Portfolio
13.7.3 Bio Basic Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.8 JPT
13.8.1 JPT Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.8.2 JPT Peptide API CDMO Services Product Portfolio
13.8.3 JPT Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.9 Genscript
13.9.1 Genscript Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.9.2 Genscript Peptide API CDMO Services Product Portfolio
13.9.3 Genscript Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.10 Xinbang Pharma
13.10.1 Xinbang Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.10.2 Xinbang Pharma Peptide API CDMO Services Product Portfolio
13.10.3 Xinbang Pharma Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.11 ScinoPharm
13.11.1 ScinoPharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.11.2 ScinoPharm Peptide API CDMO Services Product Portfolio
13.11.3 ScinoPharm Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.12 SN Biopharm
13.12.1 SN Biopharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.12.2 SN Biopharm Peptide API CDMO Services Product Portfolio
13.12.3 SN Biopharm Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.13 CBL
13.13.1 CBL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.13.2 CBL Peptide API CDMO Services Product Portfolio
13.13.3 CBL Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.14 Piramal Pharma
13.14.1 Piramal Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.14.2 Piramal Pharma Peptide API CDMO Services Product Portfolio
13.14.3 Piramal Pharma Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.15 CPC Scientific
13.15.1 CPC Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.15.2 CPC Scientific Peptide API CDMO Services Product Portfolio
13.15.3 CPC Scientific Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
14 INDUSTRY CHAIN ANALYSIS
14.1 Peptide API CDMO Services Industry Chain Analysis
14.2 Peptide API CDMO Services Typical Downstream Customers
14.3 Peptide API CDMO Services Sales Channel Analysis
15 RESEARCH FINDINGS AND CONCLUSION
16 METHODOLOGY AND DATA SOURCE
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer
1.1 Product Definition and Statistical Scope
1.2 Peptide API CDMO Services Product by Type
1.2.1 GMP Services
1.2.2 Non-GMP Services
1.3 Peptide API CDMO Services Product by Application
1.3.1 Commercial
1.3.2 Scientific Research
1.3.3 Other
1.4 Global Peptide API CDMO Services Market Size Analysis (2020-2032)
1.5 Peptide API CDMO Services Market Development Status and Trends
1.5.1 Peptide API CDMO Services Industry Development Status Analysis
1.5.2 Peptide API CDMO Services Industry Development Trends Analysis
2 PEPTIDE API CDMO SERVICES MARKET PESTEL ANALYSIS
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 PEPTIDE API CDMO SERVICES MARKET PORTER'S FIVE FORCES ANALYSIS
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 GLOBAL PEPTIDE API CDMO SERVICES MARKET ANALYSIS BY REGIONS
4.1 Global Peptide API CDMO Services Overall Market: 2024 VS 2025 VS 2032
4.2 Global Peptide API CDMO Services Revenue and Forecast Analysis (2020-2032)
4.2.1 Global Peptide API CDMO Services Revenue and Market Share by Region (2020-2025)
4.2.2 Global Peptide API CDMO Services Revenue Forecast by Region (2026-2032)
5 GLOBAL PEPTIDE API CDMO SERVICES MARKET SIZE BY TYPE AND APPLICATION
5.1 Global Peptide API CDMO Services Market Size by Type (2020-2032)
5.2 Global Peptide API CDMO Services Market Size by Application (2020-2032)
6 NORTH AMERICA
6.1 North America Peptide API CDMO Services Market Size and Growth Rate Analysis (2020-2032)
6.2 North America Key Suppliers Analysis
6.3 North America Peptide API CDMO Services Market Size by Type
6.4 North America Peptide API CDMO Services Market Size by Application
6.5 North America Peptide API CDMO Services Market Size by Country
6.5.1 US
6.5.2 Canada
7 EUROPE
7.1 Europe Peptide API CDMO Services Market Size and Growth Rate Analysis (2020-2032)
7.2 Europe Key Suppliers Analysis
7.3 Europe Peptide API CDMO Services Market Size by Type
7.4 Europe Peptide API CDMO Services Market Size by Application
7.5 Europe Peptide API CDMO Services Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 CHINA
8.1 China Peptide API CDMO Services Market Size and Growth Rate Analysis (2020-2032)
8.2 China Key Suppliers Analysis
8.3 China Peptide API CDMO Services Market Size by Type
8.4 China Peptide API CDMO Services Market Size by Application
9 APAC (EXCL. CHINA)
9.1 APAC (excl. China) Peptide API CDMO Services Market Size and Growth Rate Analysis (2020-2032)
9.2 APAC (excl. China) Key Suppliers Analysis
9.3 APAC (excl. China) Peptide API CDMO Services Market Size by Type
9.4 APAC (excl. China) Peptide API CDMO Services Market Size by Application
9.5 APAC (excl. China) Peptide API CDMO Services Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Southeast Asia
10 LATIN AMERICA
10.1 Latin America Peptide API CDMO Services Market Size and Growth Rate Analysis (2020-2032)
10.2 Latin America Key Suppliers Analysis
10.3 Latin America Peptide API CDMO Services Market Size by Type
10.4 Latin America Peptide API CDMO Services Market Size by Application
10.5 Latin America Peptide API CDMO Services Market Size by Country
10.5.1 Mexico
10.5.2 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Peptide API CDMO Services Market Size and Growth Rate Analysis (2020-2032)
11.2 Middle East & Africa Key Suppliers Analysis
11.3 Middle East & Africa Peptide API CDMO Services Market Size by Type
11.4 Middle East & Africa Peptide API CDMO Services Market Size by Application
11.5 Middle East & Africa Peptide API CDMO Services Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 COMPETITION BY SUPPLIERS
12.1 Global Peptide API CDMO Services Market Revenue by Key Suppliers (2021-2025)
12.2 Peptide API CDMO Services Competitive Landscape Analysis and Market Dynamic
12.2.1 Peptide API CDMO Services Competitive Landscape Analysis
12.2.2 Global Key Suppliers Headquarter Location and Key Area Sales
12.2.3 Market Dynamic
13 KEY COMPANIES ANALYSIS
13.1 Bachem
13.1.1 Bachem Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 Bachem Peptide API CDMO Services Product Portfolio
13.1.3 Bachem Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.2 PolyPeptide
13.2.1 PolyPeptide Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 PolyPeptide Peptide API CDMO Services Product Portfolio
13.2.3 PolyPeptide Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.3 CordenPharma
13.3.1 CordenPharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 CordenPharma Peptide API CDMO Services Product Portfolio
13.3.3 CordenPharma Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.4 AmbioPharm
13.4.1 AmbioPharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 AmbioPharm Peptide API CDMO Services Product Portfolio
13.4.3 AmbioPharm Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.5 USV Peptides
13.5.1 USV Peptides Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 USV Peptides Peptide API CDMO Services Product Portfolio
13.5.3 USV Peptides Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.6 Thermofischer
13.6.1 Thermofischer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 Thermofischer Peptide API CDMO Services Product Portfolio
13.6.3 Thermofischer Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.7 Bio Basic
13.7.1 Bio Basic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.7.2 Bio Basic Peptide API CDMO Services Product Portfolio
13.7.3 Bio Basic Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.8 JPT
13.8.1 JPT Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.8.2 JPT Peptide API CDMO Services Product Portfolio
13.8.3 JPT Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.9 Genscript
13.9.1 Genscript Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.9.2 Genscript Peptide API CDMO Services Product Portfolio
13.9.3 Genscript Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.10 Xinbang Pharma
13.10.1 Xinbang Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.10.2 Xinbang Pharma Peptide API CDMO Services Product Portfolio
13.10.3 Xinbang Pharma Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.11 ScinoPharm
13.11.1 ScinoPharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.11.2 ScinoPharm Peptide API CDMO Services Product Portfolio
13.11.3 ScinoPharm Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.12 SN Biopharm
13.12.1 SN Biopharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.12.2 SN Biopharm Peptide API CDMO Services Product Portfolio
13.12.3 SN Biopharm Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.13 CBL
13.13.1 CBL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.13.2 CBL Peptide API CDMO Services Product Portfolio
13.13.3 CBL Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.14 Piramal Pharma
13.14.1 Piramal Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.14.2 Piramal Pharma Peptide API CDMO Services Product Portfolio
13.14.3 Piramal Pharma Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.15 CPC Scientific
13.15.1 CPC Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.15.2 CPC Scientific Peptide API CDMO Services Product Portfolio
13.15.3 CPC Scientific Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
14 INDUSTRY CHAIN ANALYSIS
14.1 Peptide API CDMO Services Industry Chain Analysis
14.2 Peptide API CDMO Services Typical Downstream Customers
14.3 Peptide API CDMO Services Sales Channel Analysis
15 RESEARCH FINDINGS AND CONCLUSION
16 METHODOLOGY AND DATA SOURCE
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer
LIST OF TABLES
Table 1: Global Peptide API CDMO Services Market Size Growth Rate by Type, 2024 VS 2025 VS 2032 (US$ Million)
Table 2: Global Peptide API CDMO Services Market Size Growth Rate by Application, 2024 VS 2025 VS 2032 (US$ Million)
Table 3: Peptide API CDMO Services Industry Development Status
Table 4: Peptide API CDMO Services Industry Development Trends
Table 5: Global Peptide API CDMO Services Market Size by Region in US$ Million: 2024 VS 2025 VS 2032
Table 6: Global Peptide API CDMO Services Revenue by Region (2020-2025) & (US$ Million)
Table 7: Global Peptide API CDMO Services Revenue Market Share by Region (2020-2025)
Table 8: Global Peptide API CDMO Services Revenue Forecast by Region (2026-2032) & (US$ Million)
Table 9: Global Peptide API CDMO Services Revenue Market Share Forecast by Region (2026-2032)
Table 10: Global Peptide API CDMO Services Revenue Analysis by Type (2020-2025) & (US$ Million)
Table 11: Global Peptide API CDMO Services Revenue Analysis Forecast by Type (2026-2032) & (US$ Million)
Table 12: Global Peptide API CDMO Services Revenue Analysis by Application (2020-2025) & (US$ Million)
Table 13: Global Peptide API CDMO Services Revenue Analysis Forecast by Application (2026-2032) & (US$ Million)
Table 14: Key Peptide API CDMO Services Players in North America
Table 15: North America Peptide API CDMO Services Revenue by Type (2020-2025) & (US$ Million)
Table 16: North America Peptide API CDMO Services Revenue by Type (2026-2032) & (US$ Million)
Table 17: North America Peptide API CDMO Services Revenue by Application (2020-2025) & (US$ Million)
Table 18: North America Peptide API CDMO Services Revenue by Application (2026-2032) & (US$ Million)
Table 19: North America Peptide API CDMO Services Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 20: North America Peptide API CDMO Services Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 21: Key Peptide API CDMO Services Players in Europe
Table 22: Europe Peptide API CDMO Services Revenue by Type (2020-2025) & (US$ Million)
Table 23: Europe Peptide API CDMO Services Revenue by Type (2026-2032) & (US$ Million)
Table 24: Europe Peptide API CDMO Services Revenue by Application (2020-2025) & (US$ Million)
Table 25: Europe Peptide API CDMO Services Revenue by Application (2026-2032) & (US$ Million)
Table 26: Europe Peptide API CDMO Services Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 27: Europe Peptide API CDMO Services Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 28: Key Peptide API CDMO Services Players in China
Table 29: China Peptide API CDMO Services Revenue by Type (2020-2025) & (US$ Million)
Table 30: China Peptide API CDMO Services Revenue by Type (2026-2032) & (US$ Million)
Table 31: China Peptide API CDMO Services Revenue by Application (2020-2025) & (US$ Million)
Table 32: China Peptide API CDMO Services Revenue by Application (2026-2032) & (US$ Million)
Table 33: Key Peptide API CDMO Services Players in APAC (excl. China)
Table 34: APAC (excl. China) Peptide API CDMO Services Revenue by Type (2020-2025) & (US$ Million)
Table 35: APAC (excl. China) Peptide API CDMO Services Revenue by Type (2026-2032) & (US$ Million)
Table 36: APAC (excl. China) Peptide API CDMO Services Revenue by Application (2020-2025) & (US$ Million)
Table 37: APAC (excl. China) Peptide API CDMO Services Revenue by Application (2026-2032) & (US$ Million)
Table 38: APAC (excl. China) Peptide API CDMO Services Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 39: APAC (excl. China) Peptide API CDMO Services Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 40: Key Peptide API CDMO Services Players in Latin America
Table 41: Latin America Peptide API CDMO Services Revenue by Type (2020-2025) & (US$ Million)
Table 42: Latin America Peptide API CDMO Services Revenue by Type (2026-2032) & (US$ Million)
Table 43: Latin America Peptide API CDMO Services Revenue by Application (2020-2025) & (US$ Million)
Table 44: Latin America Peptide API CDMO Services Revenue by Application (2026-2032) & (US$ Million)
Table 45: Latin America Peptide API CDMO Services Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 46: Latin America Peptide API CDMO Services Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 47: Key Peptide API CDMO Services Players in Middle East & Africa
Table 48: Middle East & Africa Peptide API CDMO Services Revenue by Type (2020-2025) & (US$ Million)
Table 49: Middle East & Africa Peptide API CDMO Services Revenue by Type (2026-2032) & (US$ Million)
Table 50: Middle East & Africa Peptide API CDMO Services Revenue by Application (2020-2025) & (US$ Million)
Table 51: Middle East & Africa Peptide API CDMO Services Revenue by Application (2026-2032) & (US$ Million)
Table 52: Middle East & Africa Peptide API CDMO Services Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 53: Middle East & Africa Peptide API CDMO Services Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 54: Global Peptide API CDMO Services Market Revenue by Key Suppliers (2021-2025) & (US$ Million)
Table 55: Global Peptide API CDMO Services Revenue Market Share by Key Suppliers (2021-2025)
Table 56: Global Key Suppliers Headquarter Location and Key Area Sales
Table 57: Market Mergers & Acquisitions, Expansion
Table 58: Bachem Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 59: Bachem Peptide API CDMO Services Product Portfolio
Table 60: Bachem Peptide API CDMO Services Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 61: PolyPeptide Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 62: PolyPeptide Peptide API CDMO Services Product Portfolio
Table 63: PolyPeptide Peptide API CDMO Services Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 64: CordenPharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 65: CordenPharma Peptide API CDMO Services Product Portfolio
Table 66: CordenPharma Peptide API CDMO Services Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 67: AmbioPharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 68: AmbioPharm Peptide API CDMO Services Product Portfolio
Table 69: AmbioPharm Peptide API CDMO Services Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 70: USV Peptides Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 71: USV Peptides Peptide API CDMO Services Product Portfolio
Table 72: USV Peptides Peptide API CDMO Services Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 73: Thermofischer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 74: Thermofischer Peptide API CDMO Services Product Portfolio
Table 75: Thermofischer Peptide API CDMO Services Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 76: Bio Basic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 77: Bio Basic Peptide API CDMO Services Product Portfolio
Table 78: Bio Basic Peptide API CDMO Services Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 79: JPT Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 80: JPT Peptide API CDMO Services Product Portfolio
Table 81: JPT Peptide API CDMO Services Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 82: Genscript Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 83: Genscript Peptide API CDMO Services Product Portfolio
Table 84: Genscript Peptide API CDMO Services Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 85: Xinbang Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 86: Xinbang Pharma Peptide API CDMO Services Product Portfolio
Table 87: Xinbang Pharma Peptide API CDMO Services Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 88: ScinoPharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 89: ScinoPharm Peptide API CDMO Services Product Portfolio
Table 90: ScinoPharm Peptide API CDMO Services Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 91: SN Biopharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 92: SN Biopharm Peptide API CDMO Services Product Portfolio
Table 93: SN Biopharm Peptide API CDMO Services Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 94: CBL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 95: CBL Peptide API CDMO Services Product Portfolio
Table 96: CBL Peptide API CDMO Services Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 97: Piramal Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 98: Piramal Pharma Peptide API CDMO Services Product Portfolio
Table 99: Piramal Pharma Peptide API CDMO Services Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 100: CPC Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 101: CPC Scientific Peptide API CDMO Services Product Portfolio
Table 102: CPC Scientific Peptide API CDMO Services Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 103: Peptide API CDMO Services Typical Customer List
Table 104: Peptide API CDMO Services Distributors List
Table 1: Global Peptide API CDMO Services Market Size Growth Rate by Type, 2024 VS 2025 VS 2032 (US$ Million)
Table 2: Global Peptide API CDMO Services Market Size Growth Rate by Application, 2024 VS 2025 VS 2032 (US$ Million)
Table 3: Peptide API CDMO Services Industry Development Status
Table 4: Peptide API CDMO Services Industry Development Trends
Table 5: Global Peptide API CDMO Services Market Size by Region in US$ Million: 2024 VS 2025 VS 2032
Table 6: Global Peptide API CDMO Services Revenue by Region (2020-2025) & (US$ Million)
Table 7: Global Peptide API CDMO Services Revenue Market Share by Region (2020-2025)
Table 8: Global Peptide API CDMO Services Revenue Forecast by Region (2026-2032) & (US$ Million)
Table 9: Global Peptide API CDMO Services Revenue Market Share Forecast by Region (2026-2032)
Table 10: Global Peptide API CDMO Services Revenue Analysis by Type (2020-2025) & (US$ Million)
Table 11: Global Peptide API CDMO Services Revenue Analysis Forecast by Type (2026-2032) & (US$ Million)
Table 12: Global Peptide API CDMO Services Revenue Analysis by Application (2020-2025) & (US$ Million)
Table 13: Global Peptide API CDMO Services Revenue Analysis Forecast by Application (2026-2032) & (US$ Million)
Table 14: Key Peptide API CDMO Services Players in North America
Table 15: North America Peptide API CDMO Services Revenue by Type (2020-2025) & (US$ Million)
Table 16: North America Peptide API CDMO Services Revenue by Type (2026-2032) & (US$ Million)
Table 17: North America Peptide API CDMO Services Revenue by Application (2020-2025) & (US$ Million)
Table 18: North America Peptide API CDMO Services Revenue by Application (2026-2032) & (US$ Million)
Table 19: North America Peptide API CDMO Services Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 20: North America Peptide API CDMO Services Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 21: Key Peptide API CDMO Services Players in Europe
Table 22: Europe Peptide API CDMO Services Revenue by Type (2020-2025) & (US$ Million)
Table 23: Europe Peptide API CDMO Services Revenue by Type (2026-2032) & (US$ Million)
Table 24: Europe Peptide API CDMO Services Revenue by Application (2020-2025) & (US$ Million)
Table 25: Europe Peptide API CDMO Services Revenue by Application (2026-2032) & (US$ Million)
Table 26: Europe Peptide API CDMO Services Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 27: Europe Peptide API CDMO Services Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 28: Key Peptide API CDMO Services Players in China
Table 29: China Peptide API CDMO Services Revenue by Type (2020-2025) & (US$ Million)
Table 30: China Peptide API CDMO Services Revenue by Type (2026-2032) & (US$ Million)
Table 31: China Peptide API CDMO Services Revenue by Application (2020-2025) & (US$ Million)
Table 32: China Peptide API CDMO Services Revenue by Application (2026-2032) & (US$ Million)
Table 33: Key Peptide API CDMO Services Players in APAC (excl. China)
Table 34: APAC (excl. China) Peptide API CDMO Services Revenue by Type (2020-2025) & (US$ Million)
Table 35: APAC (excl. China) Peptide API CDMO Services Revenue by Type (2026-2032) & (US$ Million)
Table 36: APAC (excl. China) Peptide API CDMO Services Revenue by Application (2020-2025) & (US$ Million)
Table 37: APAC (excl. China) Peptide API CDMO Services Revenue by Application (2026-2032) & (US$ Million)
Table 38: APAC (excl. China) Peptide API CDMO Services Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 39: APAC (excl. China) Peptide API CDMO Services Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 40: Key Peptide API CDMO Services Players in Latin America
Table 41: Latin America Peptide API CDMO Services Revenue by Type (2020-2025) & (US$ Million)
Table 42: Latin America Peptide API CDMO Services Revenue by Type (2026-2032) & (US$ Million)
Table 43: Latin America Peptide API CDMO Services Revenue by Application (2020-2025) & (US$ Million)
Table 44: Latin America Peptide API CDMO Services Revenue by Application (2026-2032) & (US$ Million)
Table 45: Latin America Peptide API CDMO Services Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 46: Latin America Peptide API CDMO Services Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 47: Key Peptide API CDMO Services Players in Middle East & Africa
Table 48: Middle East & Africa Peptide API CDMO Services Revenue by Type (2020-2025) & (US$ Million)
Table 49: Middle East & Africa Peptide API CDMO Services Revenue by Type (2026-2032) & (US$ Million)
Table 50: Middle East & Africa Peptide API CDMO Services Revenue by Application (2020-2025) & (US$ Million)
Table 51: Middle East & Africa Peptide API CDMO Services Revenue by Application (2026-2032) & (US$ Million)
Table 52: Middle East & Africa Peptide API CDMO Services Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 53: Middle East & Africa Peptide API CDMO Services Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 54: Global Peptide API CDMO Services Market Revenue by Key Suppliers (2021-2025) & (US$ Million)
Table 55: Global Peptide API CDMO Services Revenue Market Share by Key Suppliers (2021-2025)
Table 56: Global Key Suppliers Headquarter Location and Key Area Sales
Table 57: Market Mergers & Acquisitions, Expansion
Table 58: Bachem Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 59: Bachem Peptide API CDMO Services Product Portfolio
Table 60: Bachem Peptide API CDMO Services Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 61: PolyPeptide Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 62: PolyPeptide Peptide API CDMO Services Product Portfolio
Table 63: PolyPeptide Peptide API CDMO Services Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 64: CordenPharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 65: CordenPharma Peptide API CDMO Services Product Portfolio
Table 66: CordenPharma Peptide API CDMO Services Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 67: AmbioPharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 68: AmbioPharm Peptide API CDMO Services Product Portfolio
Table 69: AmbioPharm Peptide API CDMO Services Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 70: USV Peptides Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 71: USV Peptides Peptide API CDMO Services Product Portfolio
Table 72: USV Peptides Peptide API CDMO Services Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 73: Thermofischer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 74: Thermofischer Peptide API CDMO Services Product Portfolio
Table 75: Thermofischer Peptide API CDMO Services Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 76: Bio Basic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 77: Bio Basic Peptide API CDMO Services Product Portfolio
Table 78: Bio Basic Peptide API CDMO Services Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 79: JPT Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 80: JPT Peptide API CDMO Services Product Portfolio
Table 81: JPT Peptide API CDMO Services Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 82: Genscript Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 83: Genscript Peptide API CDMO Services Product Portfolio
Table 84: Genscript Peptide API CDMO Services Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 85: Xinbang Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 86: Xinbang Pharma Peptide API CDMO Services Product Portfolio
Table 87: Xinbang Pharma Peptide API CDMO Services Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 88: ScinoPharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 89: ScinoPharm Peptide API CDMO Services Product Portfolio
Table 90: ScinoPharm Peptide API CDMO Services Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 91: SN Biopharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 92: SN Biopharm Peptide API CDMO Services Product Portfolio
Table 93: SN Biopharm Peptide API CDMO Services Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 94: CBL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 95: CBL Peptide API CDMO Services Product Portfolio
Table 96: CBL Peptide API CDMO Services Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 97: Piramal Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 98: Piramal Pharma Peptide API CDMO Services Product Portfolio
Table 99: Piramal Pharma Peptide API CDMO Services Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 100: CPC Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 101: CPC Scientific Peptide API CDMO Services Product Portfolio
Table 102: CPC Scientific Peptide API CDMO Services Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 103: Peptide API CDMO Services Typical Customer List
Table 104: Peptide API CDMO Services Distributors List
LIST OF FIGURES
Figure 1: Peptide API CDMO Services Product Pictures
Figure 2: GMP Services Picture Scope
Figure 3: Non-GMP Services Picture Scope
Figure 4: Commercial Picture Scope
Figure 5: Scientific Research Picture Scope
Figure 6: Other Picture Scope
Figure 7: Global Peptide API CDMO Services Market Size Analysis: 2024 VS 2025 VS 2032 (US$ Million)
Figure 8: Global Peptide API CDMO Services Market Revenue and Growth Rate Analysis: (2020-2032) & (US$ Million)
Figure 9: Global Peptide API CDMO Services Market Size by Region (2020-2032) & (US$ Million)
Figure 10: Global Peptide API CDMO Services Market Share Scenario by Region in Percentage: 2025 Versus 2032
Figure 11: North America Peptide API CDMO Services Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 12: North America Peptide API CDMO Services Market Share by Players in 2024
Figure 13: North America Peptide API CDMO Services Revenue Market Share by Type (2020-2032)
Figure 14: North America Peptide API CDMO Services Revenue Market Share by Application (2020-2032)
Figure 15: US Peptide API CDMO Services Revenue (2020-2032) & (US$ Million)
Figure 16: Canada Peptide API CDMO Services Revenue (2020-2032) & (US$ Million)
Figure 17: Europe Peptide API CDMO Services Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 18: Europe Peptide API CDMO Services Market Share by Players in 2024
Figure 19: Europe Peptide API CDMO Services Revenue Market Share by Type (2020-2032)
Figure 20: Europe Peptide API CDMO Services Revenue Market Share by Application (2020-2032)
Figure 21: Germany Peptide API CDMO Services Revenue (2020-2032) & (US$ Million)
Figure 22: France Peptide API CDMO Services Revenue (2020-2032) & (US$ Million)
Figure 23: United Kingdom Peptide API CDMO Services Revenue (2020-2032) & (US$ Million)
Figure 24: Italy Peptide API CDMO Services Revenue (2020-2032) & (US$ Million)
Figure 25: Spain Peptide API CDMO Services Revenue (2020-2032) & (US$ Million)
Figure 26: Benelux Peptide API CDMO Services Revenue (2020-2032) & (US$ Million)
Figure 27: China Peptide API CDMO Services Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 28: China Peptide API CDMO Services Market Share by Players in 2024
Figure 29: China Peptide API CDMO Services Revenue Market Share by Type (2020-2032)
Figure 30: China Peptide API CDMO Services Revenue Market Share by Application (2020-2032)
Figure 31: APAC (excl. China) Peptide API CDMO Services Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 32: APAC (excl. China) Peptide API CDMO Services Market Share by Players in 2024
Figure 33: APAC (excl. China) Peptide API CDMO Services Revenue Market Share by Type (2020-2032)
Figure 34: APAC (excl. China) Peptide API CDMO Services Revenue Market Share by Application (2020-2032)
Figure 35: Japan Peptide API CDMO Services Revenue (2020-2032) & (US$ Million)
Figure 36: South Korea Peptide API CDMO Services Revenue (2020-2032) & (US$ Million)
Figure 37: India Peptide API CDMO Services Revenue (2020-2032) & (US$ Million)
Figure 38: Australia Peptide API CDMO Services Revenue (2020-2032) & (US$ Million)
Figure 39: Southeast Asia Peptide API CDMO Services Revenue (2020-2032) & (US$ Million)
Figure 40: Latin America Peptide API CDMO Services Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 41: Latin America Peptide API CDMO Services Market Share by Players in 2024
Figure 42: Latin America Peptide API CDMO Services Revenue Market Share by Type (2020-2032)
Figure 43: Latin America Peptide API CDMO Services Revenue Market Share by Application (2020-2032)
Figure 44: Mexico Peptide API CDMO Services Revenue (2020-2032) & (US$ Million)
Figure 45: Brazil Peptide API CDMO Services Revenue (2020-2032) & (US$ Million)
Figure 46: Middle East & Africa Peptide API CDMO Services Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 47: Middle East & Africa Peptide API CDMO Services Market Share by Players in 2024
Figure 48: Middle East & Africa Peptide API CDMO Services Revenue Market Share by Type (2020-2032)
Figure 49: Middle East & Africa Peptide API CDMO Services Revenue Market Share by Application (2020-2032)
Figure 50: Saudi Arabia Peptide API CDMO Services Revenue (2020-2032) & (US$ Million)
Figure 51: South Africa Peptide API CDMO Services Revenue (2020-2032) & (US$ Million)
Figure 52: Global Peptide API CDMO Services Revenue Market Share by Key Suppliers in 2024
Figure 53: Global Peptide API CDMO Services Industry Competition Landscape
Figure 54: Peptide API CDMO Services Industry Chain Analysis
Figure 55: Bottom-Up and Top-Down Research Methods
Figure 56: Key Interview Objectives
Figure 57: Data Cross Validation
Figure 1: Peptide API CDMO Services Product Pictures
Figure 2: GMP Services Picture Scope
Figure 3: Non-GMP Services Picture Scope
Figure 4: Commercial Picture Scope
Figure 5: Scientific Research Picture Scope
Figure 6: Other Picture Scope
Figure 7: Global Peptide API CDMO Services Market Size Analysis: 2024 VS 2025 VS 2032 (US$ Million)
Figure 8: Global Peptide API CDMO Services Market Revenue and Growth Rate Analysis: (2020-2032) & (US$ Million)
Figure 9: Global Peptide API CDMO Services Market Size by Region (2020-2032) & (US$ Million)
Figure 10: Global Peptide API CDMO Services Market Share Scenario by Region in Percentage: 2025 Versus 2032
Figure 11: North America Peptide API CDMO Services Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 12: North America Peptide API CDMO Services Market Share by Players in 2024
Figure 13: North America Peptide API CDMO Services Revenue Market Share by Type (2020-2032)
Figure 14: North America Peptide API CDMO Services Revenue Market Share by Application (2020-2032)
Figure 15: US Peptide API CDMO Services Revenue (2020-2032) & (US$ Million)
Figure 16: Canada Peptide API CDMO Services Revenue (2020-2032) & (US$ Million)
Figure 17: Europe Peptide API CDMO Services Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 18: Europe Peptide API CDMO Services Market Share by Players in 2024
Figure 19: Europe Peptide API CDMO Services Revenue Market Share by Type (2020-2032)
Figure 20: Europe Peptide API CDMO Services Revenue Market Share by Application (2020-2032)
Figure 21: Germany Peptide API CDMO Services Revenue (2020-2032) & (US$ Million)
Figure 22: France Peptide API CDMO Services Revenue (2020-2032) & (US$ Million)
Figure 23: United Kingdom Peptide API CDMO Services Revenue (2020-2032) & (US$ Million)
Figure 24: Italy Peptide API CDMO Services Revenue (2020-2032) & (US$ Million)
Figure 25: Spain Peptide API CDMO Services Revenue (2020-2032) & (US$ Million)
Figure 26: Benelux Peptide API CDMO Services Revenue (2020-2032) & (US$ Million)
Figure 27: China Peptide API CDMO Services Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 28: China Peptide API CDMO Services Market Share by Players in 2024
Figure 29: China Peptide API CDMO Services Revenue Market Share by Type (2020-2032)
Figure 30: China Peptide API CDMO Services Revenue Market Share by Application (2020-2032)
Figure 31: APAC (excl. China) Peptide API CDMO Services Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 32: APAC (excl. China) Peptide API CDMO Services Market Share by Players in 2024
Figure 33: APAC (excl. China) Peptide API CDMO Services Revenue Market Share by Type (2020-2032)
Figure 34: APAC (excl. China) Peptide API CDMO Services Revenue Market Share by Application (2020-2032)
Figure 35: Japan Peptide API CDMO Services Revenue (2020-2032) & (US$ Million)
Figure 36: South Korea Peptide API CDMO Services Revenue (2020-2032) & (US$ Million)
Figure 37: India Peptide API CDMO Services Revenue (2020-2032) & (US$ Million)
Figure 38: Australia Peptide API CDMO Services Revenue (2020-2032) & (US$ Million)
Figure 39: Southeast Asia Peptide API CDMO Services Revenue (2020-2032) & (US$ Million)
Figure 40: Latin America Peptide API CDMO Services Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 41: Latin America Peptide API CDMO Services Market Share by Players in 2024
Figure 42: Latin America Peptide API CDMO Services Revenue Market Share by Type (2020-2032)
Figure 43: Latin America Peptide API CDMO Services Revenue Market Share by Application (2020-2032)
Figure 44: Mexico Peptide API CDMO Services Revenue (2020-2032) & (US$ Million)
Figure 45: Brazil Peptide API CDMO Services Revenue (2020-2032) & (US$ Million)
Figure 46: Middle East & Africa Peptide API CDMO Services Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 47: Middle East & Africa Peptide API CDMO Services Market Share by Players in 2024
Figure 48: Middle East & Africa Peptide API CDMO Services Revenue Market Share by Type (2020-2032)
Figure 49: Middle East & Africa Peptide API CDMO Services Revenue Market Share by Application (2020-2032)
Figure 50: Saudi Arabia Peptide API CDMO Services Revenue (2020-2032) & (US$ Million)
Figure 51: South Africa Peptide API CDMO Services Revenue (2020-2032) & (US$ Million)
Figure 52: Global Peptide API CDMO Services Revenue Market Share by Key Suppliers in 2024
Figure 53: Global Peptide API CDMO Services Industry Competition Landscape
Figure 54: Peptide API CDMO Services Industry Chain Analysis
Figure 55: Bottom-Up and Top-Down Research Methods
Figure 56: Key Interview Objectives
Figure 57: Data Cross Validation
